InMode (INMD) Total Non-Current Liabilities (2018 - 2026)
InMode (INMD) posted Total Non-Current Liabilities of $12.2 million for Q1 2026, down 2.05% sequentially from $12.5 million in Q4 2025, and down 3.3% YoY from $12.6 million in Q1 2025.
InMode (INMD) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
InMode has reported Total Non-Current Liabilities for 9 years, with the latest figure at $12.2 million in Q1 2026.
- Quarterly Total Non-Current Liabilities fell 3.3% year-over-year to $12.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.2 million (down 3.3% YoY) and the FY2025 annual result came in at $12.5 million, up 4.03% from the prior year.
- Total Non-Current Liabilities slipped to $12.2 million in Q1 2026 per INMD's latest filing, from $12.5 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $13.4 million in Q2 2025 and troughed at $7.0 million in Q1 2023.
- A 5-year average of $11.0 million and a median of $11.8 million in 2023 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities soared 64.94% in 2022, then tumbled 42.0% in 2023.
- Over 5 years, Total Non-Current Liabilities stood at $7.8 million in 2022, then surged by 51.56% to $11.8 million in 2023, then climbed by 1.91% to $12.0 million in 2024, then increased by 4.03% to $12.5 million in 2025, then declined by 2.05% to $12.2 million in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $12.2 million, $12.5 million, and $12.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | InMode | 912.51 Mn | 497.35 Mn | 71.52 Mn | 11.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.23 Mn |
| Dec 31, 2025 | 12.49 Mn |
| Sep 30, 2025 | 12.89 Mn |
| Jun 30, 2025 | 13.38 Mn |
| Mar 31, 2025 | 12.65 Mn |
| Dec 31, 2024 | 12.00 Mn |
| Sep 30, 2024 | 11.44 Mn |
| Jun 30, 2024 | 11.03 Mn |
| Mar 31, 2024 | 11.31 Mn |
| Dec 31, 2023 | 11.78 Mn |
| Sep 30, 2023 | 7.85 Mn |
| Jun 30, 2023 | 7.19 Mn |
| Mar 31, 2023 | 6.96 Mn |
| Dec 31, 2022 | 7.77 Mn |
| Sep 30, 2022 | 12.75 Mn |
| Jun 30, 2022 | 12.40 Mn |
| Mar 31, 2022 | 11.33 Mn |
| Dec 31, 2021 | 10.89 Mn |
| Sep 30, 2021 | 9.76 Mn |
| Jun 30, 2021 | 9.68 Mn |